Order results by:
| Issue | Title | |
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Demographic and comorbid factors associated with the development of medication overuse headache | Abstract similar documents |
| Ia. A. Kniazeva, D. V. Gilev, V. V. Osipova, E. R. Lebedeva | ||
| "... occurred more frequently in the MOH group (53 and 16%, respectively; p<0.001; OR 5.9; 95% CI 3.6–9.8). One ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Evaluation of the efficacy of preventive therapy in chronic migraine with or without medication overuse headache: data from a prospective study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... with medication overuse headache (MOH). Objective: to investigate the efficacy of preventive therapy of CM ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Clinical and psychoemotional characteristics of patients with medication overuse headache | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... and psychosocial aspects in the development and maintenance of medication overuse headache (MOH). It is therefore ..." | ||
| Vol 16, No 6 (2024) | Efficacy of cognitive behavioral therapy in chronic migraine and medication overuse headache: a prospective randomized trial | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... ) and medication overuse headache (MOH), but there are few randomized trials to evaluate its efficacy. Objective ..." | ||
| Vol 16, No 5 (2024) | Addiction to analgesics in patients with chronic migraine and medication-overuse headache | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... Patients with medication-overuse headache (MOH) and chronic migraine (CM) have varying degrees ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Comparative analysis of the efficacy of different treatment strategies in medication overuse headache: an open-label prospective trial | Abstract similar documents |
| A. V. Sergeev, E. A. Guziy, N. A. Kovalchuk, E. A. Sokolov, G. V. Grigoriev, G. R. Tabeeva | ||
| "... Medication overuse headache (MOH) is a common form of chronic headache with a high risk of relapse ..." | ||
| Vol 12, No 4 (2020) | Severe drug-induced headache with its possible recurrent statuses in a patient with chronic tension headache | Abstract similar documents |
| V. V. Osipova, K. V. Skorobogatykh, A. R. Artemenko, A. V. Sergeev | ||
| "... (ЛИГБ) у пациентов с первичными формами головной боли. Представлен клинический случай крайне тяжелой ..." | ||
| Vol 12, No 4 (2020) | Drug-induced headache: an analysis of therapeutic strategies | Abstract similar documents |
| P. A. Merbaum, G. R. Tabeeva, A. V. Sergeev | ||
| "... Ведение пациентов с лекарственно-индуцированной головной болью (ЛИГБ) – это нерешенная проблема ..." | ||
| Vol 13, No 3 (2021) | Role of educational programs in management of patients with medication-overuse headache | Abstract PDF (Eng) similar documents |
| A. E. Shagbazyan, N. A. Kovalchuk, G. R. Tabeeva | ||
| "... to medication-overuse headache (MOH). One of the most accessible and effective strategies for its prevention ..." | ||
| Vol 8, No 2 (2016) | Effectiveness of prolonged-release melatonin in Improving Quality of Sleep in Patients Aged 55 or Over | Abstract similar documents |
| G. V. Kovrov, M. V. Agaltsov, Z. N. Sukmarova | ||
| "... significant (p<0.0001) according to pared t-test (95% CI: 4.8; 7.3) improvement of the sleep quality: the mean ..." | ||
| Vol 16, No 3 (2024) | Analyzing the predictors of relapse in drug-induced headache: a prospective clinical and psychological study | Abstract similar documents |
| E. A. Guziy, A. V. Sergeev, G. R. Tabeeva | ||
| "... рецидива после лечения. Материал и методы. Проведен анализ характеристик 117 пациентов с ЛИГБ согласно ..." | ||
| Vol 12, No 6 (2020) | Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke | Abstract PDF (Eng) similar documents |
| S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, К. V. Sobyanin | ||
| "... .7 [30.5; 39.9] ml/m2 vs 28.5 [25.6; 34.6] ml/m2 vs 27.1 [24.5; 31.2] ml/m2 ; p< 0.001) and NT-proBNP ..." | ||
| Vol 14, No 1 (2022) | Effect of vitamin D and other indicators of phosphorus-calcium metabolism on cognitive functions and quality of life in patients with Parkinson's disease | Abstract similar documents |
| D. A. Novotnyy, N. G. Zhukova, L. P. Shperling, V. A. Stolyarova, I. A. Zhukova, A. E. Agasheva, S. V. Shtaimets, O. A. Druzhinina, I. V. Shirokikh | ||
| "... and the PDQ-39 subscale “Cognitive functions”. A joint direct impact of vitamin D levels (β=0.111; p=0.002 ..." | ||
| Vol 17, No 1 (2025) | Emotional disturbances in patients in the remote postoperative period after surgical treatment of cerebral aneurysms | Abstract PDF (Eng) similar documents |
| I. M. Shetova I.M, T. A. Shatokhin, V. A. Luk'yanchikov, A. A. Yakovlev, M. A. Piradov, V. V. Krylov | ||
| "... was found in female patients in the remote postoperative phase of surgical treatment (p<0.001 and p=0.002 ..." | ||
| Vol 16, No 3 (2024) | Therapeutic outcomes in patients with acute non-specific (musculoskeletal) pain according to the FORTE (ФОРТЕ) observational study | Abstract similar documents |
| V. A. Parfenov | ||
| "... .6±1.60 to 1.82±1.32 points according to the NRS (p<0.001), the proportion of patients with initially ..." | ||
| Vol 6, No 2 (2014) | Impact of patient information-educational preparation on clinical, financial, and economic factors and treatment satisfaction | Abstract similar documents |
| A.B. Danilov, E.V. Shevchenko | ||
| "... , качество жизни, субъективную удовлетворенность пациента лечением и финансовые аспекты, связанные с головной ..." | ||
| Vol 15, No 2 (2023) | Quality of life of patients with rheumatoid arthritis and comorbid fibromyalgia | Abstract similar documents |
| N. A. Melikova, E. S. Filatova, E. G. Filatova, A. M. Lila | ||
| "... at rest was 7 and 4 cm (p<0.001), the average score on the CSI questionnaire was 50 and 38.5 (p<0.001 ..." | ||
| Vol 8, No 1 (2016) | Changes in spastic muscles of patients with infantile cerebral palsy according to ultrasound findings | Abstract similar documents |
| S. V. Vlasenko, G. M. Kushnir, T. F. Golubeva, E. A. Osmanov, E. V. Strashko | ||
| "... ), and age at contracture formation (R=0.60; p=0.001). Analysis of USG and electromyographic findings ..." | ||
| Vol 14, No 3 (2022) | Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia | Abstract similar documents |
| T. I. Nasonova, E. V. Parfenova | ||
| "... to the NRS and was higher than in chNLBP (5.6±2.4 points; p=0.002). In the group of patients with FM compared ..." | ||
| Vol 10, No 3 (2018) | Treatment of patients with acute and subacute dorsalgia | Abstract similar documents |
| O. N. Gerasimova, V. A. Parfenov, E. Yu. Kalimeeva | ||
| "... intensity scores decreased from an average of 6.4 to 1.0; the RMD scores dropped from 6.8 to 1.4 (p<0.001 ..." | ||
| Vol 10, No 1 (2018) | Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, V. A. Parfenov, O. D. Ostroumova, E. M. Perepelova, V. A. Perepelov, E. V. Borisova | ||
| "... : right CBF, 38.5±5.9 ml/100 g/min (p = 0.0001); left CBF, 39.2±6.7 ml/100 g/min (p = 0.002), and in those ..." | ||
| Vol 15, No 6 (2023) | NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational study | Abstract similar documents |
| A. B. Danilov, A. A. Pilipovich, M. V. Pyastolova | ||
| "... on the VAS before treatment versus 10 [0; 20] after treatment; p<0.0001) and normalisation of sleep in most ..." | ||
| Vol 12, No 4 (2020) | Experience with citicoline in patients with post-stroke cognitive impairment | Abstract similar documents |
| A. N. Bogolepova, S. G. Burd, A. V. Lebedeva, E. A. Kovalenko | ||
| "... administration showed a statistically significant reduction in the severity of cognitive impairment (p<0.001 ..." | ||
| Vol 16 (2024): (Suppl. 2) | Cytokine levels in patients with multiple sclerosis and chronic neuroborreliosis | Abstract similar documents |
| N. S. Baranova, L. A. Ovsyannikova, Ya. S. Ostapenko, N. N. Spirin, A. A. Baranov, M. S. Gris, A. S. Artyukhov, Yu. V. Manyakina | ||
| "... -Rad (USA). Results. A significant increase in the levels of IL10 and IL33 (p<0.001) and a decrease ..." | ||
| Vol 13, No 4 (2021) | Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders | Abstract PDF (Eng) similar documents |
| S. V. Kotov, E. S. Novikova, A. S. Kotov | ||
| "... .07±0.27(p<0.0001); AQP4-IgG+ patients (n=6) — 1.1±0.9 and 0.17±0.41 (p=0.028); MOG-IgG+ patients (n=14 ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... scores of the MoCA (p=0.004), the 12- word recall test (p=0.0003), and the tests of literal (p=0.001 ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... was decreased in patients in group 2 (p<0.001), asymmetry of the indicator was noted, in several patients ..." | ||
| Vol 10, No 3 (2018) | Effect of indapamide/perindopril fixed-dose combination on 24-hour blood pressure and cognitive functions in treatment-naive middle-aged patients with essential arterial hypertension | Abstract similar documents |
| T. M. Ostroumova, V. A. Parfenov, O. D. Ostroumova, E. V. Borisova | ||
| "... of the so-called words in the ten-words test during both immediate (from 5.5±1.6 6.5±1.5 words; p=0.02 vs ..." | ||
| Vol 15, No 1 (2023) | Comments on the article “Consensus opinion on the management of patients with neuromyelitis optica spectrum diseases: issues of terminology and therapy” | Abstract similar documents |
| A. N. Boyko | ||
| "... Приводятся комментарии к статье, посвященной вопросу ведения пациентов с заболеваниями спектра ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | Sociocultural aspects and different types of stigmatization in epilepsy | Abstract similar documents |
| E. V. Parfenova, F. K. Rider, A. G. Gersamia | ||
| "... стороны пациентов, родственников и общества в целом. Обсуждается стигма, связанная с этим заболеванием и ..." | ||
| Vol 13, No 1 (2021) | Causes of ischemic stroke in patients younger than 45 years: analysis of data from the regional vascular center | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, Yu. A. Nurieva, L. I. Syromyatnikova | ||
| "... У пациентов молодого возраста причины ишемического инсульта (ИИ) значительно отличаются от таковых ..." | ||
| Vol 11, No 3 (2019) | Rehabilitation in acute stroke from the point of view of evidence-based medicine: possibilities of drug treatment | Abstract similar documents |
| A. A. Kulesh | ||
| "... и риски ранней и очень ранней мобилизации пациентов. Представлены данные об эффективности CIMT ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... from 19.8 to 23.3 points (p≥0.001) was observed in the omberacetam group. In other groups, an increase ..." | ||
| Vol 14, No 3 (2022) | The impact of non-motor disorders on the quality of life of patients with cervical muscular dystonia | Abstract similar documents |
| M. R. Nodel, N. I. Salouhina, V. A. Tolmacheva | ||
| "... <0.001 ), moderate strength correlation – with indicators of anxiety (r=0.65; p<0 ..." | ||
| Vol 15, No 3 (2023) | Clinical effectiveness and safety of prolonged release form of alimemazine in patients with generalized anxiety disorder | Abstract similar documents |
| Ju. E. Azimova, Yu. P. Sivolap, K. A. Ishchenko | ||
| "... .27 (p<0.0001). The proportion of patients with a decrease in the total score on the HARS scale by 50 ..." | ||
| Vol 16, No 3 (2024) | Clinical and neurophysiological features of the augmentation phenomenon in restless legs syndrome | Abstract similar documents |
| N. A. Gorbachev, A. V. Obukhova, L. A. Fedeneva, M. G. Poluektov | ||
| "... in the semantic speech activity test (p=0.049), have a higher score on the RS (p=0.001) and ISI (p=0.02 ..." | ||
| Vol 14, No 3 (2022) | Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation | Abstract similar documents |
| O. D. Ostroumova, T. M. Ostroumova | ||
| "... compared to warfarin (p<0.0001), including a 51% greater hemorrhagic stroke (HS) risk reduction (p<0.0001 ..." | ||
| Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
| Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
| "... for the following domains: physical functioning (p<0.01), role-physical functioning (p<0.001), pain intensity (p<0 ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... and anxiety (p < 0.001). Vortioxetine demonstrated an optimal balance between tolerability and clinical ..." | ||
| Vol 15, No 6 (2023) | In-hospital mortality in patients with ischemic stroke and a large cerebral artery occlusion, who underwent mechanical thrombectomy | Abstract similar documents |
| D. M. Murtazalieva, A. R. Zakaryaeva, M. A. Zolotov | ||
| "... with MTE was only 7.2%, while the proportion of patients on basic therapy was 36.9% (p<0.001). Mortality ..." | ||
| Vol 16, No 1 (2024) | Evaluation of the therapeutic efficacy of the drug Cytochrome C in the treatment of asthenia in outpatients (CITRIN study) | Abstract similar documents |
| V. Yu. Lobzin, A. Yu. Emelin, K. A. Kolmakova | ||
| "... (p<0.001), improvement in night sleep and reduction in daytime sleepiness on the Epworth scale by 65 ..." | ||
| Vol 16, No 1 (2024) | Safety and efficacy of fremanezumab in real clinical practice in patients with chronic migraine | Abstract similar documents |
| G. N. Belskaya, A. V. Krasnikov, E. A. Kiryanova, M. E. Prokopovich, E. V. Sakharova, G. V. Makarov | ||
| "... to 5.7 points (p<0.001), the HIT-6 index decreased from 66 to 55 points (p<0.001). AEs occurred in 26 ..." | ||
| Vol 6, No 3 (2014) | Psychogenic urticaria: The issues of diagnosis and optimization of therapy | Abstract similar documents |
| A. A. Pribytkov, E. A. Orlova | ||
| "... in the patients with CAU, 0.026±0.02 ng/ml in healthy individuals, and 8.46±0.95 ng/ml in the patients with PU (p ..." | ||
| Vol 15, No 6 (2023) | The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment | Abstract similar documents |
| Yu. A. Starchina, D. A. Grishina, E. A. Sokolov, V. A. Parfenov | ||
| "... , the average score on the Montreal Cognitive Assessment increased from 23.7±3.5 to 25.6±3.9 points (p<0.001 ..." | ||
| Vol 9, No 4 (2017) | Cognitive complaints and cognitive impairment in patients with chronic daily headache | Abstract PDF (Eng) similar documents |
| V. A. Golovacheva, V. A. Parfenov, A. A. Golovacheva | ||
| "... .35 (at 12-month follow-up) (p=0.002); while the subjective complaints regressed in the majority of patients ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... =0.03) and in the psychological component (from 42.9±15.9 to 45.6±15.5; p=0.02). In the group ..." | ||
| Vol 16 (2024): (Suppl. 2) | Results of tele-rehabilitation in patients with multiple sclerosis during 2020–2021 COVID-19 pandemic | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko | ||
| "... .58±118.55 m (p=0.02), the speed of information processing in PASAT test improved from 31.92±18.35 to 43 ..." | ||
| Vol 10, No 3 (2018) | Conservative treatment for patients with discogenic lumbosacral radiculopathy: results of a prospective follow-up | Abstract similar documents |
| M. A. Ivanova, V. A. Parfenov, A. I. Isaikin | ||
| "... .6±0.5, respectively, as shown by NPRC (p<0.001 vs baseline). Within a year, only one female patient ..." | ||
| Vol 16, No 4 (2024) | Aviandr is a new original drug for treating anxiety | Abstract similar documents |
| V. A. Parfenov | ||
| "... .3 % in group1, 2 and 3, respectively, indicating a significant (p < 0.002) benefit of Aviandr over PL ..." | ||
| Vol 14, No 5 (2022) | Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, O. I. Butranova | ||
| "... Для снижения риска развития нежелательных явлений и повышения приверженности пожилых пациентов ..." | ||
| Vol 14, No 1 (2022) | Treatment of spasticity in patients with the consequences of traumatic brain injury | Abstract similar documents |
| A. P. Kovalenko, I. A. Vozniuk, K. M. Naumov, V. Yu. Lobzin, S. Yu. Kirtaev | ||
| "... До 16–20% пациентов из числа всех перенесших черепно-мозговую травму (ЧМТ), независимо от степени ..." | ||
| Vol 8, No 1 (2016) | Factors determining social (interpersonal) support in patients with vertebro-spinal cord injury | Abstract similar documents |
| I. D. Boulyubash, O. S. Bashta | ||
| "... Цель исследования – изучение связей между особенностями социальной сети пациентов с последствиями ..." | ||
| Vol 9, No 2 (2017) | The psychological trajectory in a patient with vertebral and spinal cord injury sequels | Abstract similar documents |
| I. D. Boulyubash | ||
| "... траектории пациентов с ПСМТ предполагает полноценное участие в реабилитационном процессе психотерапевта ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Efficacy of generic levetiracetam (epiterra) in monotherapy for epilepsy in adult patients: preliminary results | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, I. A. Zhidkova | ||
| "... , ТEVA) у взрослых пациентов с фокальной (ФЭ) и ювенильной миоклонической (ЮМЭ) эпилепсией, которые ..." | ||
| Vol 6, No 1 (2014) | Severe dementia: diagnosis, patient management, prevention of complications | Abstract similar documents |
| A.B. Lokshina | ||
| "... пациентов с деменцией. Детально рассмотрены различия между степенями тяжести деменции, деменция тяжелой ..." | ||
| Vol 6, No 4 (2014) | Patient management in the recovery period of stroke | Abstract similar documents |
| O. V. Kosivtsova | ||
| "... пациента во многом зависит от степени восстановления утраченных функций. В свою очередь, степень их ..." | ||
| Online-first | Association of carriers of single nucleotide polymorphisms rs206787 and rs516535 in gene BRD2 and rs3743123 in gene GJD2 with juvenile myoclonic epilepsy of Caucasian patients in the Siberia | Abstract similar documents |
| O. S. Shilkina, N. A. Shnayder, S. N. Zobova, D. V. Dmitrenko, P. V. Moskaleva | ||
| "... with photoparoxysmal response (OR = 3,6; 95% CI 1,37 – 9,48; p = 0,02) in JME patients. Homozygosity of allele T (rs ..." | ||
| Vol 15, No 1 (2023) | New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program | Abstract similar documents |
| E. Y. Solovieva, P. R. Kamchatnov, L. B. Novikova, O. A. Kicherova, N. M. Khasanova | ||
| "... 24 weeks of therapy with Prospecta was 5.3 (p<0.0001). The proportion of patients who responded ..." | ||
| Vol 13, No 2 (2021) | Association of polymorphic marker Val158Met of COMT gene with depression in an open population 25–44 years old (WHO international program MONICA, epidemiological study) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, V. N. Maksimov, I. V. Gagulin, A. V. Gafarova | ||
| "... .4 years, response rate – 72%) was screened in 2013–2016 (budget framework № 0324- 2018-0001, Reg. № AAAA ..." | ||
| Vol 15, No 4 (2023) | Comorbid disorders and therapy of persistent postural perceptual dizziness | Abstract similar documents |
| E. N. Zastenskaya, L. M. Antonenko | ||
| "... .80 to 29.6±12.80 points (p<0.001), in the group with PPPD and peripheral vestibular disorders – from 49 ..." | ||
| Vol 12, No 4 (2020) | The main clinical and diagnostic characteristics of patients with low back pain and sacroiliac joint diseases (results of the IOLANTA-II study) | Abstract similar documents |
| I. A. Zolotovskaya, I. L. Davydkin | ||
| "... history that was statistically significantly longer (p<0.001). The ANOVA analysis showed that the patients ..." | ||
| Vol 15, No 2 (2023) | Clinical course and diagnosis of cerebral vein and sinus thrombosis associated with COVID-19 in young and middle-aged patients | Abstract similar documents |
| E. G. Klocheva, V. V. Goldobin, F. Z. Olimova | ||
| "... расстройств, представляющей потенциальную опасность для жизни пациента и требующей своевременного проведения ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | An open-label prospective clinical study of the efficacy and tolerability of brand-name and generic levetiracetam in the monotherapy of focal epilepsy in adults | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, I. A. Zhidkova | ||
| "... период наблюдения 1 год. Пациенты и методы. Пациенты были разделены на две группы: принимающих рЛЕВ (1 ..." | ||
| Vol 15, No 5 (2023) | Efficacy and safety of Vespireit® (buspirone) prolonged-release tablets (PR) 15 mg in the therapy of patients with functional dizziness: results of the double-blind, placebo-controlled, multicenter, randomized, phase 3 clinical trial | Abstract similar documents |
| M. V. Zamergrad, V. A. Parfenov, A. S. Agafina, N. V. Lyamina, M. M. Gavrik, L. R. Kuchumova, E. R. Barantsevich, V. S. Krasnov, A. A. Ivanova, A. L. Vladykin, K. А. Ishchenko | ||
| "... 1, which was 52.9% more than in Group 2 – 15.8% (n=21) (p<0.0001). Evaluation of all secondary ..." | ||
| Vol 10, No 2 (2018) | Diffusion tensor magnetic resonance imaging in the diagnosis of white matter lesion in middle-aged patients with uncomplicated essential hypertension | Abstract similar documents |
| V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova, V. A. Perepelov, V. A. Perepelova | ||
| "... .09, respectively; p<0.001). FA was lower in the hypertensive patients than in the healthy individuals not only ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Stigmatization of patients with epilepsy | Abstract similar documents |
| E. V. Parfenova, F. K. Rider, A. G. Gersamia | ||
| "... пациентов с эпилепсией. Рассмотрена тема когнитивных убеждений общества и пациентов, связанных с этиологией ..." | ||
| Vol 11, No 4 (2019) | Association of the carriage of BRD2 rs206787 and rs516535 and GJD2 rs3743123 polymorphisms with juvenile myoclonic epilepsy in Caucasian patients of Siberia | Abstract similar documents |
| O. S. Shilkina, N. A. Shnayder, S. N. Zobova, D. V. Dmitrenko, P. V. Moskaleva | ||
| "... in patients with JME (odds ratio (OR), 3.6; 95% confidence interval (CI), 1.37–9.48; p=0.02). We have ..." | ||
| Vol 17, No 1 (2025) | The use of antipsychotics in the real-world clinical practice in Russia (based on the results of the EPIDEMICUS program) | Abstract similar documents |
| V. E. Medvedev | ||
| "... . For other mental disorders, doctors more frequently added quetiapine to the therapy (23.2%; p<0.001 ..." | ||
| Vol 15, No 6 (2023) | Chronic dizziness: modern treatment methods taking into account comorbidity | Abstract similar documents |
| E. N. Zastenskaia, L. M. Antonenko | ||
| "... decreased from 45.59±15.47 to 29.9±12.56 points (p<0.001), the severity of anxiety according to BAI from 27 ..." | ||
| 1 - 70 of 1130 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
